Table 3.
Persistence with hormone therapy in women with breast cancer according to care-related characteristics. Rio de Janeiro, RJ, Southeastern Brazil, 2004 to 2010. (N = 5,861)
| Care-related characteristics | n | Prob. (%) of persistence until end of observation | Log-rank (p) | Wilcoxon (p) | |
|---|---|---|---|---|---|
| Type of hormone therapy | < 0.0001 | < 0.0001 | |||
| Only tamoxifen | 3,776 | 52.0 | |||
| Only aromatase inhibitors | 339 | 47.8 | |||
| Both | 1,746 | 41.1 | |||
| Surgery | < 0.0001 | < 0.0001 | |||
| Yes | 3,495 | 52.8 | |||
| No | 2,366 | 42.1 | |||
| Chemotherapy | < 0.0001 | < 0.0001 | |||
| Yes | 3,531 | 44.7 | |||
| No | 2,330 | 54.3 | |||
| Radiotherapy | 0.0005 | 0.0074 | |||
| Yes | 2,772 | 44.2 | |||
| No | 3,089 | 52.4 | |||
| Therapy combination | < 0.0001 | < 0.0001 | |||
| Only HT | 552 | 54.7 | |||
| HT and surgery | 899 | 58.0 | |||
| HT and CT | 579 | 41.5 | |||
| HT and RT | 503 | 40.2 | |||
| HT, CT and surgery | 1,059 | 52.3 | |||
| HT, RT and surgery | 376 | 63.6 | |||
| HT, CT and RT | 732 | 34.6 | |||
| HT, CT, RT and surgery | 1,161 | 45.8 | |||
| Frequency of chemotherapy | < 0.0001 | < 0.0001 | |||
| None | 2,330 | 54.3 | |||
| 1 to 3 procedures | 690 | 45.9 | |||
| 4 to 6 procedures | 1,777 | 56.8 | |||
| ≥ 7 procedures | 1,064 | 23.8 | |||
| Frequency of hospitalization | < 0.0001 | < 0.0001 | |||
| None | 961 | 63.6 | |||
| One | 2,794 | 51.0 | |||
| Two | 1,182 | 45.9 | |||
| ≥ 3 | 924 | 28.6 | |||
| Mastology (consultation) | < 0.0001 | < 0.0001 | |||
| None | 617 | 23.0 | |||
| 1 to 4 consultations | 1,001 | 20.2 | |||
| 5 to13 consultations | 2,971 | 60.0 | |||
| ≥ 14 consultations | 1,2 72 | 56.3 | |||
| Clinical oncology (consultation) | < 0.0001 | 0.0018 | |||
| None | 1,257 | 66.8 | |||
| 1 to 4 consultations | 1,674 | 57.4 | |||
| 5 to 12 consultations | 1,510 | 33.4 | |||
| ≥ 13 consultations | 1,420 | 37.9 | |||
| Other doctors (consultation) | < 0.0001 | < 0.0001 | |||
| ≤ 9 consultations | 604 | 27.7 | |||
| 10 to 22 consultations | 2,158 | 49.9 | |||
| 23 to 34 consultations | 1,635 | 55.7 | |||
| ≥ 35 consultations | 1,464 | 47.0 | |||
| Psychotherapy (consultation) | <0.0001 | < 0.0001 | |||
| None | 3,331 | 39.1 | |||
| 1 to 3 consultations | 1,971 | 59.9 | |||
| ≥ 4 consultations | 559 | 64.6 | |||
| Support treatment(consultation) | <0.0001 | < 0.0001 | |||
| None | 1,404 | 40.2 | |||
| 1 to 3 consultations | 2,010 | 42.4 | |||
| 4 to 7 consultations | 1,130 | 53.5 | |||
| ≥ 8 consultations | 1,317 | 62.3 | |||
| DTS (tests) | < 0.0001 | < 0.0001 | |||
| None | 1,112 | 39.4 | |||
| 1 test | 2,007 | 51.8 | |||
| 2 to 3 tests | 1,816 | 52.4 | |||
| ≥ 4 tests | 926 | 44.7 | |||
HT: hormone therapy; CT: chemotherapy; RT: radiotherapy; DTS: diagnosis and therapeutic services